Supratentorial extraventricular ependymal neoplasms: A clinicopathologic study of 32 patients

Cancer

Volumn 103, Issue 12, 2005, Pages 2598-2605

  Shuangshoti, Shanop ^a,d   Rushing, Elisabeth J ^b   Mena, Hernando ^b   Olsen, Cara ^c   Sandberg, Glenn D ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Ependymoma; Ki 67; p53; Ploidy; Prognosis; Supratentorial

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; PROTEIN P53; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ARTICLE; BRAIN TUMOR; CANCER GRADING; CELL CYCLE S PHASE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; DIPLOIDY; EPENDYMOMA; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMISPHERE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; LABELING INDEX; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBEPENDYMOMA;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CELL PROLIFERATION; CEREBRAL VENTRICLE NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPENDYMOMA; FEMALE; FLOW CYTOMETRY; GLIOMA, SUBEPENDYMAL; HUMANS; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; S PHASE; SUPRATENTORIAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 20444393976     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21111     Document Type: Article

References (35)

1. McLendon RE, Enterline DS, Tien RD, Thorstad WL, Bruner JM. Tumors of central neuroepithelial origin. In: Bigner DD, McLendon RE, Bruner JM (eds). Russell & Rubinstein's pathology of tumors of the nervous system. 6th ed. vol 1. London: Arnold, 1998:387-417.
2. Bailey P, Gushing H. A classification of tumors of the glioma group. Philadelphia: Lippincott, 1926.
3. Schwartz TH, Kim S, Glick RS, et al. Supratentorial ependymomas in adult patients. Neurosurgery. 1999;44:721-731.
4. Ernestus RI, Schroder R, Stutzer H, Klug N. Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 1996;12:522-526.
5. Schiffer D, Chio A, Giordana MT, et al. Histologic prognostic factors in ependymoma. Childs Nerv Syst. 1991;7:177-182.
6. Molina OM, Colina JL, Luzardo GD, et al. Extraventricular cerebral anaplastic ependymomas. Surg Neurol. 1999;51: 630-635.
7. Kleihues P, Cavenee WK, editors. Pathology & genetics of tumours of the nervous system. World Health Organization classification of tumours.: Lyon: International Agency for Research on Cancer (IARC) Press, 2000:71-81.
8. Furie DM, Provenzale JM. Supratentorial ependymomas and subependymomas: CT and MR appearance. J Comput Assist Tomogr. 1995;19:518-526.
9. Afra D, Muller W, Slowik F, Wilcke O, Budka H, Turoczy L. Supratentorial ependymomas: reports of the grading and survival periods in 80 cases, including 46 recurrence. Acta Neurochir (Wien). 1983;69:243-251.
10. Vinchon M, Soto-Ares G, Riffaud L, Ruchoux MM, Dhellemmes P. Supratentorial ependymoma in children. Pediatr Neurosurg. 2001;34:77-87.
11. Min KW, Scheithauer BW. Clear cell ependymoma. A mimic of oligodendroglioma: clinicopathological and ultrastructural considerations. Am J Surg Pathol. 1997;21:820-826.
12. Palma L, Celli P, Mariottini A, Zalaffi A, Schettini G. The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Childs Nerv Syst. 2000;16:170-175.
13. Rosenblum MK. Ependymomal tumors: a review of their diagnostic surgical pathology. Pediatr Neurosurg. 1998;28: 160-165.
14. Ralte AM, Rao S, Sharma MC, Suri A, Gaikwad S, Sarkar C. Myxopapillary ependymoma of the temporal lobe-report of a rare case of temporal lobe epilepsy. Clin Neuropathol. 2004;23:53-58.
15. Shuangshoti S, Mitphraphan W, Kanvisetsri S, et al. Astroblastoma: report of a case with microsatellite analysis. Neuropathology. 2000;20:228-232.
16. Vege KD, Giannini C, Scheithauer BW. The immunophenotype of ependymomas. Appl Immunohistochem Mol Morphol. 2000;8:25-31.
17. Brat DJ, Hirose Y, Cohen KJ, Feuerstein BG, Burger PC. Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol. 2000;10:342-352.
18. Sara A, Bruner JM, Mackay B. Ultrastructure of ependymoma. Ultrastruct Pathol. 1994;18:33-42.
19. Burger PC, Scheithauer BW. Atlas of tumor pathology: tumors of the central nervous system. Washington, DC: The Armed Forces Institute of Pathology, 1994:259-286.
20. Budka H. Non-glial specificities of immunocytochemistry for glial flbrillary acidic protein (GFAP). Triple expression of GFAP, vimentin and cytokeratins in papillary meningioma and metastasizing renal carcinoma. Acta Neuropathol (Berl). 1986;72:43-54.
21. Fouladi M, Helton K, Dalton J, et al. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer. 2003;98:2232-2244.
22. Fink KL, Rushing EJ, Schold SC Jr, Nisen PD. Infrequency of p53 mutation in ependymomas. J Neurooncol. 1996;27:111-115.
23. Vousden KH, Prives C. P53 and prognosis: view insights and further complexity. Cell. 2005;120:7-10.
24. Nozaki M, Tada M, Matsumoto R, Sawamura Y, Abe H, Iggo RD. Rare occurrence of inactivating p53 mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional essay. Acta Neuropathol (Berl). 1998;95:291-296.
25. Rushing EJ, Brown DF, Hladik CL, Risser RC, Mickey BF, White CL. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Mod Pathol. 1998;11: 464-470.
26. Zamecnik J, Snuderl M, Eckschlager T, et al. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol. 2003;16:980-991.
27. Garcia R, Bueno A, Castanon S, et al. Study of the DNA content by flow cytometry and proliferation in 281 brain tumors. Oncology. 1997;52:112-117.
28. Prayson R. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas. A study of 41 cases. Am J Clin Pathol. 1998; 110:629-634.
29. Ritter AM, Hess KR, McLendon RE, Langford LA. Ependymomas: MIB-1 proliferation index and survival. J Neurooncol. 1998;40:51-57.
30. Spaar FW, Blech M, Ahyai A. DNA-flow fluorescence: cytometry of ependymomas. Acta Neuropathol (Berl). 1986;69:153-160.
31. Salmon I, Dewitte O, Pasteels JL, et al. Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type. J Neurosurg. 1994;80:877-883.
32. Onguru O, Ulutin C, Celasun B, Gunhan O. DNA ploidy and nuclear morphometry in adult intracranial ependymomas. Clin Neuropathol 2003;22:266-272.
33. Korshunov A, Neben K, Wrobel G, et al. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am J Pathol. 2003;163:1721-1727.
34. Reni M, Brandes AA, Vavassori V, et al. A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer. 2004;100:1221-1229.
35. Smyth MD, Horn BN, Russo C, Berger MS. Intracranial ependymomas of childhood: current management strategies. Pediatr Neurosurg. 2000;33:138-150.